Eric Thomas Schmidt, Chief Financial Officer at Allogene Therapeutics, Inc. (ALLO), sold 29,900 shares at $42.32 ($1.2M) on 2020-10-15, disclosed to the SEC on 2020-10-16.
Open-market sale of $1.2M ALLO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.47 | 5,104 | $201K | 16.6% |
| 2 | $39.47 | 5,104 | $201K | 16.6% |
| 3 | $40.07 | 4,218 | $169K | 14.0% |
| 4 | $40.07 | 4,218 | $169K | 14.0% |
| 5 | $41.33 | 3,479 | $144K | 11.9% |
| 6 | $41.33 | 3,479 |
| $144K |
| 11.9% |
| 7 | $42.32 | 2,099 | $89K | 7.3% |
| 8 | $42.32 | 2,099 | $89K | 7.3% |
| 9 | $43.01 | 100 | $4K | 0.4% |
| Total | $40.48 avg | 29,900 | $1.2M | 100% |
| Filing → |
| ALLO | SELL | 2021-01-19 | $1.9M | — | Filing → |
| ALLO | SELL | 2020-11-18 | $644K | — | Filing → |
| ALLO | SELL | 2020-09-22 | $944K | — | Filing → |